Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants [Phase 1]

View source ↗

Summary

The Phase 1 study of GSK2556286 in healthy adults has been terminated. The update notes safety, tolerability and pharmacokinetics aspects of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• GSK2556286

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis | Phase 1 | Status: TERMINATED